IDH2 and central nervous system cancer: Our model achieved a good prediction performance for IDH genotype, especially on rCBV maps (83% accuracy, 76% sensitivity, 86% specificity), showing comparable or superior results to other studies employing CNN architectures on gliomas [23,25,26,31].